Ondansetron Noridem

Ondansetron, the active ingredient in Ondansetron Noridem, is a 5-HT3 receptor antagonist presented as an injectable solution for intramuscular and intravenous use. It prevents nausea and vomiting associated with chemotherapy and postoperative settings.

GNH USA supplies Ondansetron Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Ondansetron is a selective 5‑HT3 receptor antagonist used to control nausea and vomiting in several clinical situations.

Chemotherapy‑induced nausea and vomiting: reduces the incidence and severity of nausea and vomiting in patients receiving cytotoxic chemotherapy. Postoperative nausea and vomiting: prevents nausea and vomiting after surgical procedures. Radiation therapy‑induced nausea and vomiting: helps control nausea associated with radiation treatment.

Common Side Effects: - Headache: mild to moderate pain in the head region. - Constipation: reduced bowel movements or hard stools. - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Injection site reactions: pain, erythema, or swelling at the administration site. - Diarrhoea: loose or watery stools.

Serious or Rare Side Effects: - QT interval prolongation: may lead to cardiac arrhythmias. - Severe allergic reaction (anaphylaxis): difficulty breathing, rash, swelling. - Serotonin syndrome: agitation, hyperthermia, muscle rigidity. - Cardiac arrhythmia: irregular heart rhythm requiring medical attention. - Hypotension: sudden drop in blood pressure. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating therapy, consider the following safety measures.

Assess cardiac risk: evaluate QT interval and correct electrolyte imbalances. Monitor electrolytes: treat hypokalaemia or hypomagnesemia before use. Use with caution in hepatic impairment: dose adjustment may be required. Avoid in patients with known hypersensitivity to ondansetron or other 5‑HT3 antagonists. Pregnancy and lactation: use only if the potential benefit justifies the potential risk. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ondansetron may interact with several drug classes; review patient medication lists.

Major Interactions (Avoid): - Apomorphine: concurrent use can cause profound hypotension and loss of consciousness. - Other QT‑prolonging agents: increased risk of cardiac arrhythmia. - Serotonergic agents (e.g., SSRIs, MAO inhibitors): potential for serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase ondansetron plasma concentrations. - CYP2D6 inhibitors (e.g., fluoxetine): may modestly raise exposure levels. - Alcohol: may enhance central nervous system effects such as dizziness.